| pubmed-article:11497495 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11497495 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:11497495 | lifeskim:mentions | umls-concept:C1704256 | lld:lifeskim |
| pubmed-article:11497495 | lifeskim:mentions | umls-concept:C0683150 | lld:lifeskim |
| pubmed-article:11497495 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:11497495 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11497495 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11497495 | pubmed:dateCreated | 2001-8-10 | lld:pubmed |
| pubmed-article:11497495 | pubmed:abstractText | Enhanced expression of transforming growth factor-beta1 (TGF-beta1) demonstrated in human colonic mucosa of patients with ulcerative colitis (UC), indicates its possible significance in the pathogenesis of this disease. The aim of this study was to evaluate plasma TGF-beta1 concentration in patients with different degrees of colonic mucosal injury, as a possible indicator of ulcerative colitis activity. TGF-beta1 concentration was measured with an enzyme immunoassay (EIA) in plasma of 45 patients with endoscopically confirmed UC. Values observed in UC patients (40.5+/-15.9 ng/ml) were significantly higher than in healthy people (18.3+/-11.6 ng/ml) and higher than in patients with irritable colon syndrome (ICS), (20.5+/-13.6 ng/ml). The highest plasma TGF-beta1 (58.6+/-112.1 ng/ml) was in patients with the severe UC course. TGF-beta1 level analysed in all UC patients revealed significant positive correlation with scored degree of mucosal injury (r=0.396;P<0.01). Among other possible laboratory markers of the disease activity, only C-reactive protein concentration demonstrated significant correlation. Enhanced production of TGF-beta1 can be related to inflammation activity. Measurement of plasma TGF-beta1 may be considered as a biomarker of the disease activity. | lld:pubmed |
| pubmed-article:11497495 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11497495 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11497495 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11497495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11497495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11497495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11497495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11497495 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11497495 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11497495 | pubmed:issn | 1043-4666 | lld:pubmed |
| pubmed-article:11497495 | pubmed:author | pubmed-author:ProkopowiczDD | lld:pubmed |
| pubmed-article:11497495 | pubmed:author | pubmed-author:FlisiakRR | lld:pubmed |
| pubmed-article:11497495 | pubmed:author | pubmed-author:Wierci?ska-Dr... | lld:pubmed |
| pubmed-article:11497495 | pubmed:copyrightInfo | Copyright 2001 Academic Press. | lld:pubmed |
| pubmed-article:11497495 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11497495 | pubmed:day | 21 | lld:pubmed |
| pubmed-article:11497495 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:11497495 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11497495 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11497495 | pubmed:pagination | 343-6 | lld:pubmed |
| pubmed-article:11497495 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:meshHeading | pubmed-meshheading:11497495... | lld:pubmed |
| pubmed-article:11497495 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11497495 | pubmed:articleTitle | Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1. | lld:pubmed |
| pubmed-article:11497495 | pubmed:affiliation | Department of Infectious Diseases, Medical Academy of Bia?ystok, Zurawia str. 14, Bia?ystok, 15-540, Poland. alicja@priv.onet.pl | lld:pubmed |
| pubmed-article:11497495 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11497495 | lld:pubmed |
